Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06499363 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Treprostinil in Newborns With Pulmonary Hypertension; a Non-Interventional Study to Collect Data on Drug Utilization, Safety, and Effectiveness

Study acronym: NEPHY
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Oct 21, 2024 to Feb 25, 2025
    • Study sites: 0 to 4
    v3
  2. Start date: Jul 21, 2024 to Oct 21, 2024v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This observational study will seek to describe the uses and safety and efficacy outcomes of treprostinil in clinical practice in patients with persistent pulmonary hypertension (PPHN).
Trial Details
NCT Number NCT06499363
Lead Sponsor Ferrer Internacional S.A.
Conditions
(from sponsor)		 Persistent Pulmonary Hypertension of Newborn
Related terms Persistent Fetal Circulation Syndrome
Enrollment 60 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov